Working… Menu

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02395978
Recruitment Status : Recruiting
First Posted : March 24, 2015
Last Update Posted : July 12, 2019
Information provided by (Responsible Party):
BioLite, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : June 10, 2019
Estimated Study Completion Date : September 30, 2019